Disease/Infection News

RSS

Researchers investigate infertility trends in the United States from 1995 to 2019

In a new study, researchers estimated the changes in infertility in the United States (US) from 1995 to 2019.

16 Jun 2022

Prior spike protein exposures shape protection against SARS-CoV-2 Omicron variant

Researchers found that immune-boosting by SARS-CoV-2 Omicron variant is contingent on prior COVID-19 history.

16 Jun 2022

Researchers evaluate artemisinin for COVID-19 management

Researchers assessed the effectiveness of artemisinin-based antimalarials in the management of COVID-19.

16 Jun 2022

Cryo-electron microscopy structure of SARS-CoV-2 membrane protein

In a recent study posted to the bioRxiv* pre-print server, researchers illustrated the cryo-electron microscopic (cryo-EM) structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein in lipid nanodiscs to 3.5 angstroms (Å) resolution.

16 Jun 2022

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

A recent article posted to the medRxiv* preprint server assessed whether host traits like immunosuppression aids severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutational drift.

16 Jun 2022

Study confirms heightened protection from Omicron-associated hospitalizations by COVID boosters

In a recent article posted to the medRxiv* preprint server, scientists assessed the efficacy of the primary and boosted regimens of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations in preventing SARS-CoV-2 Omicron-linked hospitalizations in the United States (US).

16 Jun 2022

Nasopharyngeal microbiota influences SARS-CoV-2 infection status and severity

In a recent study posted to the medRxiv* pre-print server, Canadian researchers investigated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection altered the microbiota composition of the host’s nasopharyngeal region.

16 Jun 2022

Multiomics identifies genomic risk factors for COVID-19

In a recent Cell Systems study, researchers utilized the RefMap machine learning algorithm to correlate known genomic variations for severe COVID-19 obtained from large-scale genome-wide association studies (GWAS) with single-cell multiome profiling of human lungs.

16 Jun 2022

Obesity causes COVID vaccines to lose their efficacy more rapidly

In a recent study posted to the medRxiv* pre-print server, researchers examined a clinical cohort of severely obese people vaccinated with coronavirus disease 2019 (COVID-19) vaccines to determine the relationship between an individual's body mass index (BMI) and COVID-19-related hospitalization and mortality.

16 Jun 2022

Study tracks neurological symptoms in COVID-19 "long-haulers"

Researchers at University of California San Diego School of Medicine are conducting a longitudinal study to track neurological symptoms in COVID-19 "long-haulers."

16 Jun 2022

Vaccination provides good but temporary protection against SARS-CoV-2 omicron infection, study shows

A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 omicron variant, according to a study from researchers at Weill Cornell Medicine—Qatar.

16 Jun 2022

Evidence COVID in pregnancy can affect offspring's neurodevelopment

In a recent study published in the Jama Network Open journal, researchers investigated the impact of in utero exposure to coronavirus disease 2019 (COVID-19) on the neurodevelopment of infants.

15 Jun 2022

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Countries with female leaders recorded 40 per cent fewer COVID-19 deaths than nations governed by men, according to University of Queensland research.

15 Jun 2022

Scientists estimate the incubation period of 2022 monkeypox

In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands estimated the incubation period for monkeypox.

15 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

Disease/Infection News

Researchers investigate infertility trends in the United States from 1995 to 2019

Prior spike protein exposures shape protection against SARS-CoV-2 Omicron variant

Researchers evaluate artemisinin for COVID-19 management

Cryo-electron microscopy structure of SARS-CoV-2 membrane protein

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

Study confirms heightened protection from Omicron-associated hospitalizations by COVID boosters

Nasopharyngeal microbiota influences SARS-CoV-2 infection status and severity

Multiomics identifies genomic risk factors for COVID-19

Obesity causes COVID vaccines to lose their efficacy more rapidly

Study tracks neurological symptoms in COVID-19 "long-haulers"

Vaccination provides good but temporary protection against SARS-CoV-2 omicron infection, study shows

Evidence COVID in pregnancy can affect offspring's neurodevelopment

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Scientists estimate the incubation period of 2022 monkeypox

Fc-effector functions for selecting COVID-19 convalescent plasma

People with mental health problems at higher risk for severe COVID-19 outcomes

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

SARS-CoV-2 damages cilia

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

More than 1,000 genes linked to severe COVID-19 identified

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News